promise of gprc5d-targeted car-t therapies in multiple myeloma
Published 1 year ago • 91 plays • Length 0:36Download video MP4
Download video MP3
Similar videos
-
2:27
bms-986393, a novel anti-gprc5d car-t cell therapy, in multiple myeloma
-
0:59
the treatment of patients with t(11;14) myeloma
-
1:02:21
gprc5d and fcrh5 targeted therapies in myeloma
-
0:50
recent updates from the promise study
-
1:22
the potential use of car-t therapy following autologous transplantation in multiple myeloma
-
4:04
the future of myeloma treatment and the possibility of cure
-
57:25
transfusion decisions
-
2:53
understanding how patients relapse from car t-cell therapy
-
2:14
myeloma: why promise?
-
1:53
the future of multiple myeloma treatment
-
0:46
future developments in myeloma treatment
-
1:42
treatment options for transplant-ineligble myeloma patients: the promise of combination therapies
-
8:11
current car-t climate in multiple myeloma
-
1:39
paradigm-changing car t-cell therapy for multiple myeloma
-
4:15
car-t cells: current climate and future perspectives in multiple myeloma
-
2:17
moving towards fixed-duration treatment in multiple myeloma
-
1:36
the importance of mrd as a prognostic tool in multiple myeloma
-
0:45
novel treatment approaches in wm: the promise of immunotherapies
-
3:23
a bright future for multiple myeloma
-
0:52
mrd for multiple myeloma: is it ready for prime-time?
-
1:54
the future of multiple myeloma treatment
-
1:59
the role of upfront double auto-sct in high-risk myeloma